Evidence map›Paper›PMID 19426233›Full record

ReviewImmunological reviews2009

Sequence, structure, function, immunity: structural genomics of costimulation.

Kausik Chattopadhyay, Eszter Lazar-Molnar, Qingrong Yan, Rotem Rubinstein, Chenyang Zhan, Vladimir Vigdorovich, Udupi A Ramagopal, Jeffrey Bonanno, Stanley G Nathenson, Steven C Almo

Abstract readReview
In one paragraph

Review in Immunological reviews, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed.

  1. Article
  2. Review
  3. On the same side: VISTA and its ligands interact in cis on the cell surface.Protein science : a publication of the Protein Society · 2026
    Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Monoclonal Antibodies to CTLA-4 with Focus on Ipilimumab.Experientia supplementum (2012) · 2022
    Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Structural Basis of CD160:HVEM Recognition.Structure (London, England : 1993) · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Kausik ChattopadhyayDepartment of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, NY, USA.
Eszter Lazar-Molnar
Qingrong Yan
Rotem Rubinstein
Chenyang Zhan
Vladimir Vigdorovich
Udupi A Ramagopal
Jeffrey Bonanno
Stanley G Nathenson
Steven C Almo

Funding

SUBPROJECT 5U54GM074945 · NIGMS · SGX PHARMACEUTICALS, INC. · PI BURLEY, STEPHEN KEVIN · 2005 to 2009
$46.2M
Molecular and Structural Basis for T Cell CostimulationR01AI007289 · NIAID · YESHIVA UNIVERSITY · PI NATHENSON, STANLEY G · 1985 to 2012
$7.7M
IMMUNOLOGY AND IMMUNUNOOCOLOGY TRAINING PROGRAMT32CA009173 · NCI · YESHIVA UNIVERSITY · PI NATHENSON, STANLEY G · 1985 to 2009
$5.8M
NCI NIH HHS 5T32CA009173NCI NIH HHS T32 CA009173NIAID NIH HHS R01 AI007289NIAID NIH HHS R01AI007289NIGMS NIH HHS U54 GM074945NIGMS NIH HHS U54GM074945PHS HHS P3OCAO13330
6 · The paper itself

Abstract

summaryCostimulatory receptors and ligands trigger the signaling pathways that are responsible for modulating the strength, course, and duration of an immune response. High-resolution structures have provided invaluable mechanistic insights by defining the chemical and physical features underlying costimulatory receptor:ligand specificity, affinity, oligomeric state, and valency. Furthermore, these structures revealed general architectural features that are important for the integration of these interactions and their associated signaling pathways into overall cellular physiology. Recent technological advances in structural biology promise unprecedented opportunities for furthering our understanding of the structural features and mechanisms that govern costimulation. In this review, we highlight unique insights that have been revealed by structures of costimulatory molecules from the immunoglobulin and tumor necrosis factor superfamilies and describe a vision for future structural and mechanistic analysis of costimulation. This vision includes simple strategies for the selection of candidate molecules for structure determination and highlights the critical role of structure in the design of mutant costimulatory molecules for the generation of in vivo structure-function correlations in a mammalian model system. This integrated 'atoms-to-animals' paradigm provides a comprehensive approach for defining atomic and molecular mechanisms.

Indexed as

Amino Acid SequenceAnimalsBase SequenceCrystallography, X-RayGenomicsHumansLymphocyte ActivationMolecular Sequence DataProtein ConformationReceptors, Cell SurfaceSequence AlignmentReceptors, Cell Surface

Identifiers

PMID19426233
PMCPMC3001128

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.